» Articles » PMID: 28266673

Comparative Pharmacokinetic Profile of Cyclosporine (CsA) with a Decapeptide and a Linear Analogue

Abstract

The synthesis and in vivo pharmacokinetic profile of an analogue of cyclosporine is disclosed. An acyclic congener was also profiled in in vitro assays to compare cell permeability. The compounds possess similar calculated and measured molecular descriptors however have different behaviors in an RRCK assay to assess cell permeability.

Citing Articles

Systematic Determination of the Impact of Structural Edits on Accumulation into Mycobacteria.

Dash R, Liu Z, Lepori I, Chordia M, Ocius K, Holsinger K bioRxiv. 2025; .

PMID: 39868157 PMC: 11760776. DOI: 10.1101/2025.01.17.633618.


Synthetic-bioinformatic natural product-inspired peptides.

Nelson S, Parkinson E Nat Prod Rep. 2024; 42(1):50-66.

PMID: 39479929 PMC: 11525955. DOI: 10.1039/d4np00043a.


CycPeptMP: enhancing membrane permeability prediction of cyclic peptides with multi-level molecular features and data augmentation.

Li J, Yanagisawa K, Akiyama Y Brief Bioinform. 2024; 25(5).

PMID: 39210505 PMC: 11361855. DOI: 10.1093/bib/bbae417.


Bio-synthesis, purification and structural analysis of Cyclosporine-A produced by Tolypocladium inflatum with valorization of agro-industrial wastes.

Falah F, Samie A, Mortazavi S, Danesh A, Yazdi F, Ramezani M Sci Rep. 2024; 14(1):12540.

PMID: 38822034 PMC: 11143273. DOI: 10.1038/s41598-024-63110-y.


Engineering lanthipeptides by introducing a large variety of RiPP modifications to obtain new-to-nature bioactive peptides.

Fu Y, Xu Y, Ruijne F, Kuipers O FEMS Microbiol Rev. 2023; 47(3).

PMID: 37096385 PMC: 10373908. DOI: 10.1093/femsre/fuad017.